GEHC GE HealthCare Technologies ...

Nasdaq


$ 73.40 $ -0.55 (-0.74 %)    

Thursday, 16-Oct-2025 12:00:53 EDT
QQQ $ 602.89 $ -2.40 (-0.4 %)
DIA $ 461.91 $ -1.46 (-0.32 %)
SPY $ 664.08 $ -2.81 (-0.42 %)
TLT $ 90.90 $ 0.40 (0.44 %)
GLD $ 393.21 $ 2.06 (0.53 %)
$ 73.22
$ 74.00
$ 73.33 x 25
$ 73.40 x 1
$ 73.32 - $ 74.24
$ 57.59 - $ 94.71
3,432,901
na
33.24B
$ 1.29
$ 14.83
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 02-06-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 07-25-2023 06-30-2023 10-Q
10 04-25-2023 03-31-2023 10-Q
11 02-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-89

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $87 to $89.

 barclays-initiates-coverage-on-ge-healthcare-techs-with-equal-weight-rating-announces-price-target-of-86

Barclays analyst Matt Miksic initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight rating and announce...

 citigroup-downgrades-ge-healthcare-techs-to-neutral-lowers-price-target-to-83

Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price targe...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

 bloomberg-ge-healthcare-is-said-to-explore-selling-stake-in-china-business

https://www.bloomberg.com/news/articles/2025-09-18/ge-healthcare-is-said-to-explore-selling-stake-in-china-business?srnd=homepa...

 ge-healthcare-announced-agreement-to-acquire-icometrix-no-financial-terms-disclosed

The anticipated acquisition aligns with GE HealthCare's precision care strategy with the goal of strengthening the company&...

 ge-healthcare-announces-a-distribution-and-services-agreement-with-cardionavix-to-expand-us-access-to-flyrcado-cardiac-pet-imaging-agent

GE HealthCare's agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the rea...

 ge-healthcare-launches-vivid-pioneer-ultrasound-system-with-ce-mark-and-fda-clearance

GE HealthCare (NASDAQ:GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive car...

 citigroup-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-93

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $89...

 morgan-stanley-maintains-equal-weight-on-ge-healthcare-techs-lowers-price-target-to-74

Morgan Stanley analyst Patrick Wood maintains GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight and lowers the price tar...

 ge-healthcare-core-operating-margin-faces-tariffs-heat-raises-annual-outlook

GE HealthCare posted better-than-expected Q2 earnings and revenue and raised its 2025 EPS and free cash flow guidance on strong...

 ge-healthcare-techs-raises-fy2025-adj-eps-guidance-from-390-410-to-443-463-vs-407-est

2025 guidanceToday, the Company raises 2025 full-year guidance, reflective of healthy capital investment trends, operational ex...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION